Trial
NCT04117607
Safety and Pharmacokinetics of Rezafungin
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
—
Condition
Fungal Infection
Intervention
Placebo
Why stopped
Stopped due to the formation of injection site skin nodules.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-07-16